A simplified MRI‑based risk score and nomogram to predict initial objective response in unresectable hepatocellular carcinoma treated with HAIC, targeted therapy, and immunotherapy: a multicenter study.
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.